$75.0 Million
CymaBay Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$101.2 Million
Repare Therapeutics Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$80.5 Million
ViewRay Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$85.0 Million
Sutro Biopharma, Inc.
Initial Public Offering
Active Bookrunner
$201.3 Million
Axonics Modulation Technologies, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$30.1 Million
Otonomy, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$129.0 Million
Savara Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$64.6 Million
Jounce Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$56.5 Million
Marker Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$69.4 Million
Kaleido Biosciences
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.